BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19947240)

  • 1. [Head-up tilt test--do we really know all about it?].
    Plásek J; Doupal V; Hrabovská Z
    Vnitr Lek; 2009 Oct; 55(10):955-60. PubMed ID: 19947240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-up tilt test for recurrent syncope in pilots.
    Carter D; Pokroy R; Grossman A; Azaria B; Goldstein L
    Aviat Space Environ Med; 2005 Dec; 76(12):1167-9. PubMed ID: 16370268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Situational syncope: response to head-up tilt testing and follow-up: comparison with vasovagal syncope.
    Livanis EG; Leftheriotis D; Theodorakis GN; Flevari P; Zarvalis E; Kolokathis F; Kremastinos DT
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):918-23. PubMed ID: 15271010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the efficiency of the head-up tilt test with nitroglycerin challenge in the diagnosis of vasovagal syncope.
    Podoleanu C; Frigy A; Dobreanu D; Micu S; Podoleanu D; Incze A; Caraşca E
    Rom J Intern Med; 2004; 42(3):585-94. PubMed ID: 16366132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between results of head-up tilt test and clinical features in patients with syncope or presyncope.
    Emkanjoo Z; Alizadeh A; Alasti M; Fadaie AA; Haghjoo M; Fazelifar AF; Sadr-Ameli MA
    J Electrocardiol; 2007 Apr; 40(2):200-2. PubMed ID: 16963069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical findings as predictors of positivity of head-up tilt table test in neurocardiogenic syncope.
    Asensio E; Oseguera J; Loría A; Gómez M; Narváez R; Dorantes J; Hernández P; Orea A; Rebollar V; Ocaranza R
    Arch Med Res; 2003; 34(4):287-91. PubMed ID: 12957525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differential behaviour of blood pressure in patients with neurocardiogenic syncope during the initial stage of the tilt table test].
    Asensio Lafuente E; Colín Ramírez E; Castillo Martínez L; Oseguera Moguel J; Narváez David R; Dorantes García J; Galindo Uribe J; Orea Tejeda A
    Arch Cardiol Mex; 2006; 76(1):59-62. PubMed ID: 16749503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is home orthostatic self-training effective in preventing neurally mediated syncope?
    On YK; Park J; Huh J; Kim JS
    Pacing Clin Electrophysiol; 2007 May; 30(5):638-43. PubMed ID: 17461874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of tilt-table test result in patients with malignant neurocardiogenic syncope.
    Omar AR; Ng KS; Ng WL; Sutandar A
    Intern Med J; 2004 Aug; 34(8):504-6. PubMed ID: 15317550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The tilt-table test: is it essential for adequate treatment of vasovagal syncope? Arguments in favor].
    Moya i Mitjans A; Permanyer-Miralda G; Sagristà Sauleda J; Rius Gelabert T
    Rev Esp Cardiol; 1997 Jun; 50(6):368-73. PubMed ID: 9304159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tilt testing: is it necessary in all patients with suspected vaso-vagal syncope?
    Kulakowski P; Piotrowska D; Konofolska A
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):968-74. PubMed ID: 16176537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of head-up tilt test result: is it possible?
    Turk U; Alioglu E; Kirilmaz B; Duygu H; Tuzun N; Tengiz I; Zoghi M; Ercan E
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):153-8. PubMed ID: 19889180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-up tilt table testing in syncope: safety and efficiency of isosorbide versus isoproterenol in pediatric population.
    Swissa M; Epstein M; Paz O; Shimoni S; Caspi A
    Am Heart J; 2008 Sep; 156(3):477-82. PubMed ID: 18760129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion.
    Aslan O; Guneri S; Badak O; Kirimli O; Goldeli O; Keskin V; Akdeniz B; Tekin U
    Can J Cardiol; 2002 Aug; 18(8):853-9. PubMed ID: 12215748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in circulatory biogenic amines during head-up tilt testing in neurocardiogenic syncope.
    Bhargava B; Chandra S; Kacker V; Gupta YK; Kaul U; Seth SD; Wasir HS
    Indian Heart J; 1996; 48(6):659-62. PubMed ID: 9062013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study.
    Foglia-Manzillo G; Giada F; Gaggioli G; Bartoletti A; Lolli G; Dinelli M; Del Rosso A; Santarone M; Raviele A; Brignole M
    Europace; 2004 May; 6(3):199-204. PubMed ID: 15121070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The tilt-table test: is it essential for adequate treatment of vasovagal syncope? Arguments against].
    Ruiz Granell R; García Civera R; Morell Cabedo S; Botella Solana S; López Merino V
    Rev Esp Cardiol; 1997 Jun; 50(6):374-82. PubMed ID: 9304160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of provocative tests for unexplained syncope: isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope.
    Graham LA; Gray JC; Kenny RA
    Eur Heart J; 2001 Mar; 22(6):497-503. PubMed ID: 11237545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of nocturnal fainting: supine vasovagal syncope.
    Marrison VK; Parry SW
    Europace; 2007 Sep; 9(9):835-6. PubMed ID: 17562749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formal analysis of the optimal duration of tilt testing for the diagnosis of neurally mediated syncope.
    Stein KM; Slotwiner DJ; Mittal S; Scheiner M; Markowitz SM; Lerman BB
    Am Heart J; 2001 Feb; 141(2):282-8. PubMed ID: 11174344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.